Immunosuppressive Agents: all 5,940 studies that test it
Page 48 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- Randomized Trial of Cyclosporine and Tacrolimus Therapy With Steroid Withdrawal in Living-Donor Renal TransplantationCompletedNCT00777933Not applicable
- Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.Status unknownNCT00777673Phase 2
- Rapamycin in With High-Dose Etoposide and Cytarabine in Relapsed/Refractory Aggressive Lymphoid MalignanciesTerminatedNCT00776373Phase 1/2
- Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001CompletedNCT00775073Phase 2
- A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast CancerCompletedNCT00773695Phase 2
- A Safety and Efficacy Study of Golimumab (CNTO148) in Patients With Active Rheumatoid Arthritis (RA)CompletedNCT00771251Phase 3
- Thalidomide in Treating Patients With Relapsed or Progressive Systemic MastocytosisCompletedNCT00769587
- FCR or BR in Patients With Previously Untreated B-Cell Chronic Lymphocytic LeukemiaCompletedNCT00769522Phase 3
- Safety of Immunosuppression Minimization in Children and Adolescents After Kidney TransplantationCompletedNCT00768729Phase 1
- Diabetogenicity of Cyclosporine and TacrolimusCompletedNCT00766909Phase 4
- Phase 2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Combination With Lucentis® in Patients With Age-Related Macular DegenerationTerminatedNCT00766337Phase 2
- Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic LeukemiaStatus unknownNCT00764907Phase 3
- Safety and Efficacy of TAK-715 in Subjects With Rheumatoid ArthritisCompletedNCT00760864Phase 2
- A Phase II Study of Doxorubicin, Cyclophosphamide and Vindesine With Valproic Acid in Patients With Refractory or Relapsing Small Cell Lung Cancer After Platinum Derivatives and EtoposideCompletedNCT00759824Phase 2
- Tacrolimus Versus Clobetasol Propionate in the Treatment of Vulvar Lichen SclerosusCompletedNCT00757874Phase 2
- A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid TumorsCompletedNCT00756340Phase 1
- "Steroids and Azathioprine Versus Steroids Alone in IgAN"CompletedNCT00755859Phase 4
- Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung TransplantationCompletedNCT00755781Phase 3
- Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing VasculitidesStatus unknownNCT00751517Phase 2
- Allogeneic Hematopoietic Stem Cell TransplantationStatus unknownNCT00750126Phase 2
- Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in ChildrenCompletedNCT00749723Phase 2/3
- High-Dose Melphalan and a Second Stem Cell Transplant or Low-Dose Cyclophosphamide in Treating Patients With Relapsed Multiple Myeloma After ChemotherapyStatus unknownNCT00747877Phase 3
- Effects of Intra-articular Versus Subacromial Steroid Injections on Clinical Outcomes in Adhesive CapsulitisWithdrawnNCT00742846Not applicable
- Extension Study of Semapimod 60 mg IV x 3 DaysCompletedNCT00741910Phase 2
- Veliparib, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Non-Hodgkin LymphomaActive, not recruitingNCT00740805Phase 1
- Long-term Study of Semapimod (CNI-1493) for Treatment of Crohn's DiseaseCompletedNCT00740103Phase 2
- Semapimod for Treatment of Moderate to Severe Crohn's Disease 1 or 3 Days' Treatment Versus PlaceboCompletedNCT00739986Phase 2
- Flu+CPM+rATG Conditioning Regimes for Unrelated Bone Marrow Transplantation (UBMT)(or Mobilized Peripheral Blood)in Severe Aplastic Anemia (SAA)Status unknownNCT00737685Phase 2
- Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSLWithdrawnNCT00734773Early Phase 1
- Anti-T-Lymphocyte Globulin (ATG) in Renal Transplantation of Kidneys With a Non-Heart-Beating (NHB) DonorStatus unknownNCT00733733Phase 3
- Pharmacokinetics (PK) and Metabolism of FTY720 in Patients With Severe Renal Impairment and Healthy Matched Subjects.CompletedNCT00731523Phase 1
- Etanercept in New Onset Type 1 DiabetesCompletedNCT00730392Phase 1/2
- RAD001 and Lenalidomide in the Treatment of Subjects With Relapsed and Relapsed/Refractory Multiple MyelomaCompletedNCT00729638Phase 1
- Low-Dose Thalidomide as Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular CarcinomaStatus unknownNCT00728078Phase 2/3
- A Safety and Efficacy Study of Golimumab (CNTO 148) in Patients With Active Rheumatoid Arthritis Despite Methotrexate TherapyCompletedNCT00727987Phase 3
- Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System LymphomaCompletedNCT00727831Phase 1/2
- Everolimus in Treating Older Patients With Mantle Cell Lymphoma Previously Treated With First-Line or Second-Line ChemotherapyTerminatedNCT00727207Phase 2
- Phase IV Study to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal TransplantationCompletedNCT00724022Phase 4
- S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom MacroglobulinemiaWithdrawnNCT00723658Phase 2
- Comparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma PatientsTerminatedNCT00722098Phase 2
- Thalidomide in Pediatric Inflammatory Bowel Diseases.CompletedNCT00720538Phase 3
- A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients.CompletedNCT00720408Phase 3
- A Study to Assess the Safety and Efficacy of Prograf and MR4 in Kidney Transplantation PatientsCompletedNCT00720265Phase 3
- A Study to Assess the Safety and Efficacy of Prograf and MR4 in Liver Transplant RecipientsCompletedNCT00719745Phase 3
- Effect of Aprepitant on Cyclophosphamide Pharmacokinetics in Patients With Breast CancerCompletedNCT00719173Phase 1
- A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Kidney Transplant RecipientsCompletedNCT00717678Phase 3
- A Study in Kidney Transplant Subjects to Investigate the Optimal Suppression of Immunity to Help Prevent Kidney RejectionCompletedNCT00717470Phase 4
- Study of Tacrolimus Immunosuppressive Therapy After Kidney TransplantationCompletedNCT00717379Phase 4
- Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal FailureCompletedNCT00716573Phase 4
- Autologous Stem Cell Transplant for Neurologic Autoimmune DiseasesActive, not recruitingNCT00716066Phase 2
- Thymoglobulin: Presence and Affect in the Central Lymphatic CompartmentCompletedNCT00714480Not applicable
- A Single Arm, Multicenter, Phase II Trial of RAD001 as Monotherapy in the Palliative Treatment of Patients With TCC After Failure of ChemotherapyCompletedNCT00714025Phase 2
- Phase 1/2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Age-Related Macular DegenerationTerminatedNCT00712491Phase 1/2
- Role of Intraoperative Thymoglobulin in Decreasing Ischemia-Reperfusion Injury in Pediatric Heart Transplant RecipientsWithdrawnNCT00709293Not applicable
- Study of Rapamycin Plus Ketoconazole in Advanced CancersCompletedNCT00708591Phase 1
- Rapamycin in Advanced CancersCompletedNCT00707135Phase 1
- Two Combination Chemotherapy Regimens in Treating Children With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00707083Phase 3
- Thymoglobulin in Calcineurin Inhibitor and Steroid Minimization ProtocolStatus unknownNCT00706680Phase 4
- Treatment of Severe Osteogenesis Imperfecta by Allogeneic Bone Marrow TransplantationCompletedNCT00705120Phase 1
- Study Evaluating Enbrel Drug Levels in Healthy Male Chinese SubjectsCompletedNCT00705042Phase 1
- Safety and Efficacy of Azacitidine, and Thalidomide in Higher Risk MDS (Myelodysplastic Syndrome)Status unknownNCT00704704Phase 2
- Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial CancersCompletedNCT00703807Phase 1
- Population Pharmacokinetics of Benznidazole in Children With Chagas DiseaseCompletedNCT00699387Not applicable
- Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell TransplantCompletedNCT00697684Phase 1
- Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic MalignanciesCompletedNCT00697671Phase 1
- Study to Evaluate Effect of Everolimus in Progression of Graft Vascular Illness on Patients With Heart TransplantStatus unknownNCT00695344Phase 4
- Sequential Therapy (FK506 + Monoclonal Anti-IL2R Antibodies + MMF) Versus FK506 With Steroids in Liver TXCompletedNCT00693524Phase 2
- A Study To Compare Sirolimus Versus Tacrolimus In De Novo Simultaneous Pancreas- Kidney Allograft Recipients Receiving An Induction Therapy With Antithymocyte Globulin Plus Mycophenolate Mofetil Plus CorticosteroidsStatus unknownNCT00693446Phase 4
- Mycophenolate Mofetil (MMF) Discontinuation From a Tacrolimus/MMF/Steroid Triple Regimen After Kidney TransplantationCompletedNCT00693381Phase 3
- A Study of MK0140 in Diabetic Patients With Macular Edema (0140-001)TerminatedNCT00692614Phase 2
- Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic DermatitisCompletedNCT00691262Phase 3
- Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic DermatitisCompletedNCT00691145Phase 3
- Protopic Ointment in Adult Atopic Eczema of the FaceCompletedNCT00690105Phase 4
- Protopic Ointment in Children Atopic EczemaCompletedNCT00689832Phase 4
- Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast CancerCompletedNCT00689156Phase 3
- Fludara (Oral) Phase II Study for Indolent LymphomaCompletedNCT00688883Phase 2
- Total Marrow Irradiation for Refractory Acute LeukemiaCompletedNCT00686556Phase 1
- Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Deceased Donor Renal TransplantationCompletedNCT00685061Phase 4
- BK Viremia After Renal TransplantationStatus unknownNCT00684372Not applicable
- Dendritic Cells (White Blood Cells) Vaccination for Advanced MelanomaCompletedNCT00683670Phase 1
- Daclizumab Versus Thymoglobulin in Renal Transplant Recipients With High Immunological RiskCompletedNCT00682292Phase 3
- Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Living Donor Renal TransplantationCompletedNCT00681343Phase 4
- Tacrolimus/Sirolimus Versus Tacrolimus/Mycophenolate Mofetil (MMF) Versus Neoral/Sirolimus in Adult, Primary Kidney TransplantationCompletedNCT00681213Phase 4
- Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast CancerCompletedNCT00680758Phase 1
- Allogeneic Transplantation for Pediatric Leukemias With Unrelated DonorsStatus unknownNCT00679536Phase 1/2
- Evaluation of The Efficacy And Safety of Intra-Articular Etanercept in Patients With Refractory Knee Joint SynovitisCompletedNCT00678782Phase 2
- Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin LymphomaCompletedNCT00678327Phase 3
- Chronic Graft-versus-host Disease (cGvHD) Prophylaxis With or Without ATG Prior to Stem Cell Transplantation (SCT) From HLA-identical Siblings in Patients With Acute LeukemiaCompletedNCT00678275Phase 3
- A Clinical Trial Evaluating the Safety and Effectiveness of Golimumab in Patients With Severe, Persistent AsthmaWithdrawnNCT00675649Phase 2
- Trastuzumab With or Without Everolimus in Treating Women With Breast Cancer That Can Be Removed By SurgeryTerminatedNCT00674414Phase 2
- Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory LymphomaTerminatedNCT00671112Phase 1
- A Study Using Tacrolimus, Sirolimus and Bortezomib as Acute Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Peripheral Blood Stem Cell (PBSC) TransplantationCompletedNCT00670423Phase 1
- Autologous Transplant Followed by Allogeneic Transplant for High Risk NeuroblastomaTerminatedNCT00670410Phase 1
- Autologous Bone Marrow Transplant for Children With Acute Myelogenous Leukemia (AML) in First Complete RemissionCompletedNCT00667927Phase 1
- Rapamycin Plus Bevacizumab in Advanced CancersCompletedNCT00667485Phase 1
- Treatment of Macroglobulinemic Lymphoma With 2CdA, Cyclophosphamide and RituximabCompletedNCT00667329Phase 1
- Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic DermatitisCompletedNCT00667160Phase 4
- Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact DermatitisCompletedNCT00667056Phase 4
- Combination Chemotherapy in Treating Younger Patients With Hodgkin LymphomaCompletedNCT00666484Phase 2
- Dose Response and Safety Study of Topical Methotrexate for the Treatment of Fingernail PsoriasisStatus unknownNCT00666354Phase 2